AssetMark Inc’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $124K | Sell |
4,199
-310
| -7% | -$9.17K | ﹤0.01% | 1322 |
|
|
2025
Q1 | $135K | Sell |
4,509
-180
| -4% | -$5.37K | ﹤0.01% | 1222 |
|
|
2024
Q4 | $134K | Sell |
4,689
-202
| -4% | -$5.79K | ﹤0.01% | 1189 |
|
|
2024
Q3 | $189K | Sell |
4,891
-524
| -10% | -$20.2K | ﹤0.01% | 1025 |
|
|
2024
Q2 | $174K | Buy |
5,415
+514
| +10% | +$16.6K | ﹤0.01% | 1024 |
|
|
2024
Q1 | $190K | Sell |
4,901
-544
| -10% | -$21.1K | ﹤0.01% | 950 |
|
|
2023
Q4 | $168K | Buy |
5,445
+1,108
| +26% | +$34.1K | ﹤0.01% | 951 |
|
|
2023
Q3 | $96.9K | Buy |
4,337
+281
| +7% | +$6.28K | ﹤0.01% | 993 |
|
|
2023
Q2 | $87.2K | Buy |
4,056
+1,231
| +44% | +$26.5K | ﹤0.01% | 976 |
|
|
2023
Q1 | $67.8K | Buy |
2,825
+885
| +46% | +$21.2K | ﹤0.01% | 967 |
|
|
2022
Q4 | $45K | Buy |
1,940
+264
| +16% | +$6.13K | ﹤0.01% | 1067 |
|
|
2022
Q3 | $27K | Buy |
1,676
+575
| +52% | +$9.26K | ﹤0.01% | 1074 |
|
|
2022
Q2 | $20K | Buy |
1,101
+646
| +142% | +$11.7K | ﹤0.01% | 1114 |
|
|
2022
Q1 | $9K | Buy |
+455
| New | +$9K | ﹤0.01% | 1201 |
|